News & Events

• July 29, 2018
  

  Perceived Burden of Completion of Patient-Reported Outcome Measures in Clinical Trials: Results of a Preliminary Study

  Bodart, S B B, Crescioni, M E S,, Flood, E and on behalf of the ePRO C. Perceived Burden of Completion of Patient-Reported Outcome Measures in Clinical Trials: Results of a Preliminary Study. Therapeutic Innovation & Regulatory Science [Internet]. 2018 Jul 29.
• July 26, 2018
  

  First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials

  FOR IMMEDIATE RELEASE Contact: Kissy Black 615.298.1144 kissyblack@lotosnile.com   Tucson, AZ — July 26, 2018 – The Critical Path Institute’s (C-Path) Critical Path for Parkinson’s Consortium (CPP), in partnership with Parkinson’s UK, announces that the European Medicines Agency (EMA) has issued a positive qualification opinion on an imaging test (biomarker) as a tool to enrich...
• July 12, 2018
  

  Hippocampal Volume as an Enrichment Biomarker in Trials of Patients with Mild Cognitive Impairment

• July 12, 2018
  

  Facilitating rapid data and information sharing by establishing a sustainable, integrated, and standardized platform advancing knowledge to enable expedited drug development

• July 5, 2018
  

  Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments